Role of bacterial colonization in neonatal necrotizing enterocolitis and its prevention

D Dai1, W A Walker

  • 1Shanghai Institute for Pediatric Research, Shanghai Second Medical University, China.

Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi [Journal]. Zhonghua Minguo Xiao Er Ke Yi Xue Hui
|February 2, 1999
PubMed

Insights

Necrotizing enterocolitis (NEC) in premature infants is linked to abnormal gut bacteria. Modulating the infant gut microbiome with interventions like probiotics may prevent this serious condition.

Area of Science:

  • Neonatal Medicine
  • Microbiology
  • Gastroenterology

Background:

  • Necrotizing enterocolitis (NEC) is a critical gastrointestinal issue in premature infants.
  • The interaction between gut bacteria and the immature digestive system is central to NEC's development.
  • Diet and environment significantly shape the gut's microbial ecosystem.

Purpose of the Study:

  • To explore the role of aberrant gut bacterial colonization in NEC pathogenesis.
  • To investigate how factors like breastfeeding, probiotics, and prebiotics influence the neonatal gut microbiome.
  • To identify potential strategies for preventing and treating NEC through microbiome manipulation.

Main Methods:

  • Comparative analysis of gut microbiota in breast-fed versus formula-fed infants.
  • Examination of bacterial colonization patterns in premature neonates, particularly those in intensive care.
  • Review of the impact of human milk oligosaccharides, probiotics, and prebiotics on gut microflora.

Main Results:

  • Premature infants often exhibit delayed and aberrant gut bacterial colonization compared to full-term infants.
  • Breastfeeding promotes a beneficial microbiota dominated by bifidobacteria, offering protection against NEC.
  • Formula-fed infants and those in intensive care show a predominance of potentially harmful bacteria.

Conclusions:

  • Aberrant colonization of the premature infant gut is a significant factor in NEC development.
  • Human milk components, probiotics, and prebiotics can positively modulate the gut microbiome.
  • Targeting and manipulating neonatal gut bacteria presents a promising avenue for NEC prevention and treatment.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...